Pregnancy: Pravastatin is contraindicated during pregnancy and should be administered to women of childbearing potential only when such patients are unlikely to conceive and have been informed of the potential risk. Special caution is recommended in adolescent females of childbearing potential to ensure proper understanding of the potential risk associated with pravastatin therapy during pregnancy. If a patient plans to become pregnant or becomes pregnant, the doctor has to be informed immediately and pravastatin should be discontinued because of the potential risk to the foetus.
Breastfeeding: A small amount of pravastatin is excreted in human breast-milk, therefore pravastatin is contraindicated during breastfeeding (see Contraindications).
Other Services
Country
Account